FLT-3
7 drugs OncologyRespiratory
5
approved indications
7
Approved Drugs
7
Companies
15
Indications
2
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (7 companies)
✓ All 7 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (15 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
EXELIXIS INC 1 drug
Viatris 1 drug
Bayer 1 drug
By Therapeutic Area
Other 4 drugs
Oncology 2 drugs
By Therapeutic Area
Other 4 drugs
CABOMETYX, NEXAVAR, COMETRIQ, RESNIBEN
Oncology 2 drugs
SORAFENIB TOSYLATE, ALUNBRIG
Respiratory 1 drugs
OFEV
Indications Treated
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid CarcinomaNon-Small Cell Lung CancerMedullary Thyroid CancerAdvanced renal cell carcinomaHepatocellular carcinoma previously treated with sorafenibLocally advanced or metastatic differentiated thyroid cancerWell-differentiated pancreatic neuroendocrine tumorsWell-differentiated extra-pancreatic neuroendocrine tumorsUnresectable hepatocellular carcinomaLocally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatmentIdiopathic Pulmonary FibrosisInterstitial Lung DiseaseSystemic Sclerosis-Associated Interstitial Lung Disease